Name: Drug Discovery. Traditional Approaches and Advanced Strategies
Price: 205.04 EUR
Availability: InStock
Author: Renren, PhD Bai
ISBN: 9780443405150

portada Drug Discovery. Traditional Approaches and Advanced Strategies

Drug Discovery. Traditional Approaches and Advanced Strategies

Type

Physical Book

Publisher

Academic Press Inc

Author

Renren, PhD Bai

Year

2026

Pages

450

Format

Paperback

Dimensions

23.50 x 19.10 cm

ISBN13

9780443405150

Drug Discovery. Traditional Approaches and Advanced Strategies

Renren, Phd Bai (Author) · Academic Press Inc · Paperback

New Book Imported to Netherlands

Delivery: 16 Oct - 23 Oct

€ 205,04

Import costs and 9% BTW included in the price ✅

€ 205,04

Add to Wishlist

Synopsis "Drug Discovery. Traditional Approaches and Advanced Strategies"

Drug Discovery: Traditional Approaches and Advanced Strategies is a foundational monograph that connects established methodologies, cutting-edge technologies, and the transformative impact of AI and other emerging tools in the drug discovery landscape. Sections provide an overview of drug discovery and development, introducing current trends and the evolving landscape of the field, explore traditional approaches alongside advanced strategies, covering topics such as drug target discovery, lead optimization, and the revolutionary role of artificial intelligence in drug discovery, and investigate promising emerging technologies, including targeted protein degradation and innovative design strategies. Equipping readers with insights into the future of drug development, this is a vital resource for academic and industrial researchers, students, and professionals seeking to stay at the forefront of drug discovery. By integrating traditional methodologies with the latest advancements, this book not only enhances understanding but also inspires innovation. With practical case studies and real-world applications, it empowers researchers to effectively implement new technologies, ultimately improving the efficiency and success rates of their R&D endeavors.